Surgery Partners closes $1.4B term loan refinancing, extending maturity to 2030

Surgery Partners, Inc.

$1.4B aggregate principal of 2024 Refinancing Term Loans priced at Term SOFR + 2.75% or base rate + 1.75%.
New loans mature December 19, 2030 and replace all existing term loans under the credit agreement.
Amortization: equal quarterly installments of 0.25% of original principal, starting Q3 2024.
Voluntary prepayments subject to 1% call premium if made within 6 months due to a repricing event.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.